Global enzyme replacement therapy market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The global enzyme replacement therapy market is segmented on the basis of type, application and region. The injectable agents segment accounted for the largest share in the global enzyme replacement therapy market in 2018 and is expected to continue its dominance throughout the forecast period. Oral agents are expected to witness significant growth during the forecast period owing to their ease of administration and convenience over injectable agents. Gaucher disease accounted for a major share in terms of application in 2018 due to its high prevalence among patients with lysosomal storage disorders (LSDs). Fabry disease was also among one of the most prevalent LSDs globally, which led it being ranked as one of top five diseases by WHO in 2017. MPS disease was also among top five diseases by WHO in 2017 due to its high prevalence worldwide and lack of treatment options available for this condition till date. Gastrointestinal diseases were also among top five diseases by WHO due to their high prevalence worldwide and lack of treatment options available for this condition till date.
- The increasing incidence of chronic diseases such as diabetes mellitus type 1 and 2 will drive the demand for enzyme replacement therapies over the forecast period owing to their efficacy in treating these conditions which are becoming more prevalent globally due to changing lifestyles and dietary habits coupled with lack of physical activity among people across all age groups.
- In addition, increasing awareness about various types of enzymes used in treatment will also fuel growth during the forecast period owing to their ability in restoring normal metabolic functions that have been impaired due to various reasons such as genetic disorders or infections like HIV/AIDS or hepatitis B or C virus infection (HBV/HCV) 5) Increasing research on novel enzymes that can be used for treatment purposes will also boost growth during the forecast period owing to their ability in restoring normal metabolic functions that have been impaired due to various reasons such as genetic disorders or infections like HIV/AIDS or hepatitis B or C virus infection (HBV/HCV).
Industry Growth Insights published a new data on “Enzyme Replacement Therapy Market”. The research report is titled “Enzyme Replacement Therapy Market research by Types (Injectable Agents, Oral Agents), By Applications (Gaucher Disease, Fabry Disease, MPS Disease, Gastrointestinal Disease, Others), By Players/Companies Sanofi, Takeda, BioMarin, AbbVie, Alexion, Allergan, Horizon Pharma, Johnson & Johnson, Actelion, Recordati Rare Diseases, Pfizer, Digestive Care, Leadiant Biosciences”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Enzyme Replacement Therapy Market Research Report
By Type
Injectable Agents, Oral Agents
By Application
Gaucher Disease, Fabry Disease, MPS Disease, Gastrointestinal Disease, Others
By Companies
Sanofi, Takeda, BioMarin, AbbVie, Alexion, Allergan, Horizon Pharma, Johnson & Johnson, Actelion, Recordati Rare Diseases, Pfizer, Digestive Care, Leadiant Biosciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Enzyme Replacement Therapy Market Report Segments:
The global Enzyme Replacement Therapy market is segmented on the basis of:
Types
Injectable Agents, Oral Agents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gaucher Disease, Fabry Disease, MPS Disease, Gastrointestinal Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Takeda
- BioMarin
- AbbVie
- Alexion
- Allergan
- Horizon Pharma
- Johnson & Johnson
- Actelion
- Recordati Rare Diseases
- Pfizer
- Digestive Care
- Leadiant Biosciences
Highlights of The Enzyme Replacement Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injectable Agents
- Oral Agents
- By Application:
- Gaucher Disease
- Fabry Disease
- MPS Disease
- Gastrointestinal Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Enzyme Replacement Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Enzyme replacement therapy (ERT) is a treatment for people with rare diseases that are caused by a lack of enzymes. Enzymes are proteins that help the body to break down food. People with rare diseases can't produce enough enzymes, which can lead to health problems. ERT involves giving people supplements containing enzymes.
Some of the major companies in the enzyme replacement therapy market are Sanofi, Takeda, BioMarin, AbbVie, Alexion, Allergan, Horizon Pharma, Johnson & Johnson, Actelion, Recordati Rare Diseases, Pfizer, Digestive Care, Leadiant Biosciences.
The enzyme replacement therapy market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Enzyme Replacement Therapy Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Enzyme Replacement Therapy Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Enzyme Replacement Therapy Market - Supply Chain
4.5. Global Enzyme Replacement Therapy Market Forecast
4.5.1. Enzyme Replacement Therapy Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Enzyme Replacement Therapy Market Size (000 Units) and Y-o-Y Growth
4.5.3. Enzyme Replacement Therapy Market Absolute $ Opportunity
5. Global Enzyme Replacement Therapy Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Enzyme Replacement Therapy Market Size and Volume Forecast by Type
5.3.1. Injectable Agents
5.3.2. Oral Agents
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Enzyme Replacement Therapy Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Enzyme Replacement Therapy Market Size and Volume Forecast by Application
6.3.1. Gaucher Disease
6.3.2. Fabry Disease
6.3.3. MPS Disease
6.3.4. Gastrointestinal Disease
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Enzyme Replacement Therapy Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Enzyme Replacement Therapy Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Enzyme Replacement Therapy Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Enzyme Replacement Therapy Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Enzyme Replacement Therapy Demand Share Forecast, 2019-2026
9. North America Enzyme Replacement Therapy Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Enzyme Replacement Therapy Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Enzyme Replacement Therapy Market Size and Volume Forecast by Application
9.4.1. Gaucher Disease
9.4.2. Fabry Disease
9.4.3. MPS Disease
9.4.4. Gastrointestinal Disease
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Enzyme Replacement Therapy Market Size and Volume Forecast by Type
9.7.1. Injectable Agents
9.7.2. Oral Agents
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Enzyme Replacement Therapy Demand Share Forecast, 2019-2026
10. Latin America Enzyme Replacement Therapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Enzyme Replacement Therapy Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Enzyme Replacement Therapy Market Size and Volume Forecast by Application
10.4.1. Gaucher Disease
10.4.2. Fabry Disease
10.4.3. MPS Disease
10.4.4. Gastrointestinal Disease
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Enzyme Replacement Therapy Market Size and Volume Forecast by Type
10.7.1. Injectable Agents
10.7.2. Oral Agents
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Enzyme Replacement Therapy Demand Share Forecast, 2019-2026
11. Europe Enzyme Replacement Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Enzyme Replacement Therapy Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Enzyme Replacement Therapy Market Size and Volume Forecast by Application
11.4.1. Gaucher Disease
11.4.2. Fabry Disease
11.4.3. MPS Disease
11.4.4. Gastrointestinal Disease
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Enzyme Replacement Therapy Market Size and Volume Forecast by Type
11.7.1. Injectable Agents
11.7.2. Oal Agents
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Enzyme Replacement Therapy Demand Share, 2019-2026
12. Asia Pacific Enzyme Replacement Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Enzyme Replacement Therapy Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Enzyme Replacement Therapy Market Size and Volume Forecast by Application
12.4.1. Gaucher Disease
12.4.2. Fabry Disease
12.4.3. MPS Disease
12.4.4. Gastrointestinal Disease
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Enzyme Replacement Therapy Market Size and Volume Forecast by Type
12.7.1. Injectable Agents
12.7.2. Oral Agents
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Enzyme Replacement Therapy Demand Share, 2019-2026
13. Middle East & Africa Enzyme Replacement Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Enzyme Replacement Therapy Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Enzyme Replacement Therapy Market Size and Volume Forecast by Application
13.4.1. Gaucher Disease
13.4.2. Fabry Disease
13.4.3. MPS Disease
13.4.4. Gastrointestinal Disease
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Enzyme Replacement Therapy Market Size and Volume Forecast by Type
13.7.1. Injectable Agents
13.7.2. Oral Agents
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Enzyme Replacement Therapy Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Enzyme Replacement Therapy Market: Market Share Analysis
14.2. Enzyme Replacement Therapy Distributors and Customers
14.3. Enzyme Replacement Therapy Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sanofi
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Takeda
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BioMarin
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. AbbVie
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Alexion
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Allergan
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Horizon Pharma
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Johnson & Johnson
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Actelion
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Recordati Rare Diseases
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Pfizer
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Digestive Care
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Leadiant Biosciences
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook